GLP2 TIRZ
GLP-2 Tirz is a peptide construct studied in research models for its relationship with incretin signaling pathways and gastrointestinal metabolic regulation mechanisms [1,2].
This peptide is for research purposes only. Not for human consumption.
Description
Incretin Signaling Context
GLP-2 is part of the glucagon peptide family and is examined for its role in gut-associated signaling and nutrient response pathways [1]. Tirzepatide-based analogs allow researchers to explore extended receptor interaction and pathway modulation within incretin-related systems.
Metabolic and Gastrointestinal Research
Studies evaluate GLP-2 signaling in relation to intestinal growth, nutrient absorption markers, and metabolic regulation [2]. These investigations focus on receptor activation patterns and downstream pathway markers.
Peptide Design Considerations
Modified incretin peptides are often used to assess signaling persistence, receptor selectivity, and pathway cross-talk under controlled experimental conditions [1].
Key Specs
- Peptide class: GLP-2–based analog
- Research context: incretin and metabolic signaling
- References: PubChem, PubMed [1,2]
Referenced Citations
- PubChem, Glucagon-Like Peptide-2: https://pubchem.ncbi.nlm.nih.gov/compound/Glucagon-like-peptide-2
- PubMed, GLP-2 signaling pathways: https://pubmed.ncbi.nlm.nih.gov/11723157/
Additional information
| Size | 5MG, 10MG, 15MG |
|---|
Incretin Signaling Context
GLP-2 is part of the glucagon peptide family and is examined for its role in gut-associated signaling and nutrient response pathways [1]. Tirzepatide-based analogs allow researchers to explore extended receptor interaction and pathway modulation within incretin-related systems.
Metabolic and Gastrointestinal Research
Studies evaluate GLP-2 signaling in relation to intestinal growth, nutrient absorption markers, and metabolic regulation [2]. These investigations focus on receptor activation patterns and downstream pathway markers.
Peptide Design Considerations
Modified incretin peptides are often used to assess signaling persistence, receptor selectivity, and pathway cross-talk under controlled experimental conditions [1].
Key Specs
- Peptide class: GLP-2–based analog
- Research context: incretin and metabolic signaling
- References: PubChem, PubMed [1,2]
Referenced Citations
- PubChem, Glucagon-Like Peptide-2: https://pubchem.ncbi.nlm.nih.gov/compound/Glucagon-like-peptide-2
- PubMed, GLP-2 signaling pathways: https://pubmed.ncbi.nlm.nih.gov/11723157/
Reviews
There are no reviews yet.